Molecular genetic study of hypertension

Acta Cardiologica Sinica

Volumn 20, Issue 3, 2004, Pages 129-138

  Chern, Tser Haw ^a,c   Chiang, Fu Tien ^b  

^a Bureau of National Health Insurance Taiwan   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Taipei Outpatient Clinic   (Taiwan)

Author keywords

Association analysis; Candidate genes; Genetic markers; Genetics; Hypertension; Linkage analysis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADDUCIN; ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; SODIUM CHANNEL;

ANIMAL MODEL; BLOOD PRESSURE; CANDIDATE GENE; CHROMOSOME 15Q; CHROMOSOME 17; CHROMOSOME 18Q; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 5Q; CHROMOSOME 6Q; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FAMILIAL DISEASE; GENE; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; GENOME; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; LIDDLE SYNDROME; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 9444286427     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Feinleib M, Garrison RJ, Fabsitz R, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 1977;106:284-5.
2. Biron P, Mongeau JG, Bertrand D. Familial aggregation of blood pressure in 558 adopted children. Can Med Assoc J 1976;115: 773-4.
3. Liddle GW, Bledsoe T, Coppage WS. A familial renal disorder simulating aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963;76:199-213.
4. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994;79: 407-14.
5. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995;11:6-9.
6. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966;95:1109-19.
7. Gomez-Sanchez CE, Montgomery M, Ganguly A, et al. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 1984;59:1022-4.
8. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355:262-5.
9. Mune T, Rogerson FM, Nikkilä H, et al. Human hypertension caused by mutations in the kidney isozyme of 11 β-hydroxysteroid dehydrogenase. Nat Genet 1995;10:394-9.
10. Geller DS, Farhi A, Pinkerton N, et al. Activating of mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000;289:119-23.
11. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983;80: 6056-60.
12. Dudley C, Keavney B, Casadei B, et al. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 1996;14:259-62.
13. Dieguez-Lucena JL, Aranda-Lara P, Ruiz-Galdon M, et al. Angiotensin I-converting enzyme genotypes and agiotensin II receptors. Response to therapy. Hypertension 1996;28:98-103.
14. Qu H, Lu Y, Lin S, et al. Meta-analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population. Chin J Prev Med 2001;35:408-11.
15. Hingorani AD, Jia H, Stevens PA, et al. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995;13: 1602-9.
16. Zee RYL, Lou YK, Griffiths LR, et al. Association of a polymorphism of the angiotensin 1-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
17. Jeunemaitre X, Lifton RP, Hunt SC, et al. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-5.
18. Schmidt S, van Hooft IMS, Grobbee DE, et al. Polymorphism of the angiotensin 1 converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993;11:345-8.
19. Chuang LM, Chiu KC, Chiang FT, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolisms 1997;46:1211-4.
20. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71: 169-80.
21. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
22. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-92.
23. Hingorani AD, Sharma P, Jia H, et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996;28:907-11.
24. Kato N, Sugiyama T, Morita H, et al. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 1999;17:757-63.
25. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-97.
26. Wang JH, Lin CM, Wang LS, et al. Association between molecular variants of the angiotensinogen gene and hypertension in Amis tribes of eastern Taiwan. J Formos Med Assoc 2002;101:183-8.
27. Chiang FT, Hsu KL, Tseng CD, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997;15:607-11.
28. Wu SJ, Chiang FT, Jiang JR, et al. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens 2003; 21:2061-7.
29. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994;24:63-9.
30. Jin W, Liu Y, Sheng HH, et al. Single nucleotide polymorphisms in promoter of angiotensin II type1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population. Acta Pharmacol Sin 2003;24:1083-8.
31. Baker EH, Dong YB, Sagnella GA, et al. Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in London. Lancet 1998;351:1388-92.
32. Ambrosius WT, Bloem LJ, Zhou L, et al. Genetic variant in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension 1999;34:631-7.
33. Wong ZYH, Stebbing M, Ellis JA, et al. Genetic linkage of β and γ subunits of epithelial sodium channel to systolic blood pressure. Lancet 1999;353:1222-5.
34. Lovati E, Ferrari P, Dick B, et al. Molecular basis of human salt sensitivity: the role of 11 β-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 1999;84:3745-9.
35. Melander O, Orho-Melander M, Bengtsson K, et al. The role of the 11 beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 2000;18:971-2.
36. 2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens 1999;12:853-7.
37. Timmermann B, Mo R, Luft FC, et al. β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998;53:1455-60.
38. 2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther 2000;67:670-5.
39. 2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002;20:229-35.
40. Shoji M, Tsutaya S, Saito R, et al. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sciences 2000;26:2557-62.
41. Tsujita Y, Baba S, Yamauchi R, et al. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens 2001;19:1941-8.
42. Takami S, Wong ZYH, Stebbing M, et al. Linkage analysis of endothelial nitric oxide synthase gene with human blood pressure. J Hypertens 1999;17:1431-6.
43. Cusi D, Barlassina C, Azzani T, et al. Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997;349:1353-7.
44. Kato N, Sugiyama T, Nabika T, et al. Lack of association between the α-adducin locus and essential hypertension in the Japanese population. Hypertension 1998;31:730-3.
45. He X, Zhu DL, Chu SL, et al. α-Adducin and essential hypertension in China. Clin and Exper Hypertens 2001;23:579-89.
46. Rutledge DR, Sun Y, Rosa EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995;13:953-5.
47. Chiang FT, Tseng CD, Hsu KL, et al. Atrial natriuretic peptide gene polymorphism is not associated with essential hypertension: evidence of association with ethnic origin. J Hum Hypertens 1996;10:304.
48. Ruhmutula D, Nakayama T, Soma M, et al. Association study between the variants of the human ANP gene and essential hypertension. Hypertension Res 2001;24:291-4.
49. Cheung BM, Leung R, Shiu S, et al. HpaII polymorphism in the atrial natriuretic peptide gene and hypertension. Am J Hypertens 1999;12:524-7.
50. Baima J, Nicolaou M, Schwarz F, et al. Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension 1999;34:4-7.
51. Xu X, Rogus JJ, Terwedow HA, et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet. 1999;64:1694-701.
52. Krushkal J, Ferrell R, Mockrin SC, et al. Genome-wide linkage analysis of systolic blood pressure using highly discordant siblings. Circulation 1999;99:1407-10.
53. Hsueh WC, Mitchell BD, Schneider JL, et al. QTL influencing blood pressure maps to the regions of PPH1 on chromosome 2q31-34 in Old Order Amish. Circulation 2000;101:2810-6.
54. Levy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36:477-83.
55. Kristjansson K, Manolescu A, Kristinsson A, et al. Linkage of essential hypertension to chromosome 18q. Hypertension 2002; 39:1044-9.
56. Wu SY, Fann CS, Jou YS, et al. Association between markers in chromosome region 17q23 and young onset hypertension: a TDT study. J Med Genet 2002;39:42-4.
57. Ge D, Yang W, Huang J, et al. Linkage analysis of 2q14-q23 and 5q32 with blood pressure quantitative traits in Chinese sib pairs. J Hypertens 2003;21:305-10.
58. Nabika T, Kobayashi Y, Yamori Y. Congenic rats for hypertension: How useful are they for the hunting of hypertension genes? Clin Exp Pharmacol Physiol 2000;27:251-6.
59. Iwai N, Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension 1991;17:161-9.
60. Hübner N, Lee YA, Lindpaintner K, et al. Congenic substitution mapping excludes Sa as a candidate gene locus for blood pressure quantitative trait locus on rat chromosome 1. Hypertension 1999;34:643-8.
61. Aitman TJ, Gotoda T, Evans AL, et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet 1997;16:197-201.
62. Aitman T, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21:76-83.
63. Pravenec M, Kurtz TW. Genetics of Cd36 and the metabolic syndrome. Semin Nephrol 2002;22:148-53.
64. Pravenec M, Landa V, Zidek V, et al. Transgenic expression CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 2003;52:681-8.
65. Hubert P, Lindpaintner K, Beckmann JS, et al. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 1991;353: 521-9.
66. Jacob HJ, Lindpaintner K, Lincoln SE, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rats. Cell 1991;67:213-24.
67. Kreutz R, Hübner N. Congenic rat strains are important tools for genetic dissection of essential hypertension. Semin Nephrol 2002; 22:135-47.
68. Tsai CT, Fallin D, Chiang FT, et al. Angiotensionogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003;41:9-15.
69. Koopmans RP, Insel PA, Michel MC. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 2003;13:705-13.